192 related articles for article (PubMed ID: 31782787)
1. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
[TBL] [Abstract][Full Text] [Related]
2. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
[TBL] [Abstract][Full Text] [Related]
4. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
[TBL] [Abstract][Full Text] [Related]
5. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
7. Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.
Ikawa T; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
Arthritis Res Ther; 2021 Nov; 23(1):283. PubMed ID: 34774095
[TBL] [Abstract][Full Text] [Related]
8. A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Exp Dermatol; 2015 Feb; 24(2):127-32. PubMed ID: 25421497
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
[TBL] [Abstract][Full Text] [Related]
10. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
[TBL] [Abstract][Full Text] [Related]
11. A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
Taniguchi T; Miyagawa T; Tamaki Z; Nakamura K; Yamashita T; Saigusa R; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Tada Y; Sugaya M; Kadono T; Sato S; Asano Y
Arch Dermatol Res; 2017 Dec; 309(10):833-842. PubMed ID: 29038846
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
13. Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.
Ichimura Y; Asano Y; Akamata K; Takahashi T; Noda S; Taniguchi T; Toyama T; Aozasa N; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Arch Dermatol Res; 2014 May; 306(4):331-8. PubMed ID: 24292093
[TBL] [Abstract][Full Text] [Related]
14. A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.
Takahashi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Toyama T; Taniguchi T; Yoshizaki A; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2016 Dec; 175(6):1195-1203. PubMed ID: 27105895
[TBL] [Abstract][Full Text] [Related]
15. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
[TBL] [Abstract][Full Text] [Related]
16. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
17. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
[TBL] [Abstract][Full Text] [Related]
18. Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis.
Yamashita K; Kawasaki A; Matsushita T; Furukawa H; Kondo Y; Okiyama N; Nagaoka S; Shimada K; Sugii S; Katayama M; Hirohata S; Okamoto A; Chiba N; Suematsu E; Setoguchi K; Migita K; Sumida T; Tohma S; Hamaguchi Y; Hasegawa M; Sato S; Kawaguchi Y; Takehara K; Tsuchiya N
Rheumatology (Oxford); 2020 Nov; 59(11):3553-3562. PubMed ID: 32696043
[TBL] [Abstract][Full Text] [Related]
19. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
20. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]